New prostate cancer treatment on trial

  • Posted

Posted 05/03/2013

A study carried out by Imperial College in London reports that skin patches delivering oestrogen into the blood stream may be a better, and also cheaper, method of treatment for prostate cancer sufferers than the current therapy which is to inject a testosterone-cutting chemical.Testosterone is the driving force behind the growth of many prostrate cancers so treatment has been concentrated on cutting testosterone levels in sufferers. However, current treatment with injections which reduce both oestrogen and testosterone has side effects such as poor bone health and diabetes. It is hoped that treatment with patches would avoid these side effects. Initial studies are promising and a wider study is now going on with long term follow up to establish how treating with patches rather than the current injections compares with respect to long term efficacy. This is all against a background of the trebling in the risk of prostate cancer which was reported in January.Trefine Maynard, a clinical negligence solicitor at Ashtons Legal, says: “It is encouraging to see the optimistic results from the early studies into this new treatment. As more and more men are diagnosed with the disease, investment in better treatments can only be really welcome news for sufferers and for the medical profession.”


    How can we help you?

    Please fill in the form and we’ll get back to you as soon as possible or to speak to one of our experts call
    0330 404 0749

    I accept that my data will be held for the purpose of my enquiry in accordance with Ashtons
    Privacy Policy

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    How can we help?

    If you have an enquiry or you would like to find out more about our services, why not contact us?